185 related articles for article (PubMed ID: 23457941)
1. [Clinical significance of sentinel lymph node micrometastases in invasive breast carcinoma].
Tsugawa K
Nihon Geka Gakkai Zasshi; 2013 Jan; 114(1):22-7. PubMed ID: 23457941
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and management of sentinel node micrometastasis in invasive breast cancer.
Jafferbhoy S; McWilliams B
Clin Breast Cancer; 2012 Oct; 12(5):308-12. PubMed ID: 23039999
[TBL] [Abstract][Full Text] [Related]
3. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
[TBL] [Abstract][Full Text] [Related]
4. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
[TBL] [Abstract][Full Text] [Related]
5. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
6. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.
Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH
Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511
[TBL] [Abstract][Full Text] [Related]
7. Pathologic Evaluation and Prognostic Implications of Nodal Micrometastases in Breast Cancer.
Dutta SW; Volaric A; Morgan JT; Chinn Z; Atkins KA; Janowski EM
Semin Radiat Oncol; 2019 Apr; 29(2):102-110. PubMed ID: 30827448
[TBL] [Abstract][Full Text] [Related]
8. [Micrometastasis: biological entity and clinical impact?].
Houvenaeghel G; Cohen M; Bannier M; Buttarelli M; Jauffret C; Lambaudie E
Bull Cancer; 2013 Apr; 100(4):351-6. PubMed ID: 23531428
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of occult metastases in axillary sentinel lymph nodes of breast carcinoma.
Amir AS; Azar FP; Sahram N; Naser FM; Na'ma MR; Farid F; Khatoon AN; Ramin S; Ali TK
Pol J Pathol; 2012 Mar; 63(1):40-4. PubMed ID: 22535605
[TBL] [Abstract][Full Text] [Related]
11. Non-sentinel lymph node status and prognosis of breast cancer patients with micrometastatic sentinel lymph nodes.
Onishi T; Jinno H; Takahashi M; Hayashida T; Sakata M; Nakahara T; Shigematsu N; Mukai M; Kitagawa Y
Eur Surg Res; 2010; 45(3-4):344-9. PubMed ID: 21088425
[TBL] [Abstract][Full Text] [Related]
12. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
13. Is the presence of small volume disease in the sentinel node an indication for axillary clearance?
Patten DK; Leff DR; Wani Z; Cleator SJ; Palmieri C; Coombes RC; Hadjiminas DJ
Breast; 2013 Feb; 22(1):70-3. PubMed ID: 22721758
[TBL] [Abstract][Full Text] [Related]
14. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?
Galimberti V; Botteri E; Chifu C; Gentilini O; Luini A; Intra M; Baratella P; Sargenti M; Zurrida S; Veronesi P; Rotmensz N; Viale G; Sonzogni A; Colleoni M; Veronesi U
Breast Cancer Res Treat; 2012 Feb; 131(3):819-25. PubMed ID: 21468637
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph nodes with isolated tumour cells and micrometastases in breast cancer: clinical relevance and prognostic significance.
Ahmed SS; Thike AA; Iqbal J; Yong WS; Tan B; Madhukumar P; Ong KW; Ho GH; Wong CY; Tan PH
J Clin Pathol; 2014 Mar; 67(3):243-50. PubMed ID: 24218025
[TBL] [Abstract][Full Text] [Related]
16. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance.
Youssef MMG; Cameron D; Pucher PH; Olsen S; Ferguson D
Breast; 2016 Dec; 30():101-104. PubMed ID: 27668857
[TBL] [Abstract][Full Text] [Related]
17. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
18. Significance and management of micrometastases in patients with breast cancer.
Mittendorf EA; Hunt KK
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1451-61. PubMed ID: 17944569
[TBL] [Abstract][Full Text] [Related]
19. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
